KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Return on Assets (2016 - 2025)

Historic Return on Assets for AbbVie (ABBV) over the last 13 years, with Q3 2025 value amounting to 0.02%.

  • AbbVie's Return on Assets fell 200.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.03% for FY2024, which is 0.0% changed from last year.
  • Latest data reveals that AbbVie reported Return on Assets of 0.02% as of Q3 2025, which was down 200.0% from 0.03% recorded in Q2 2025.
  • AbbVie's Return on Assets' 5-year high stood at 0.09% during Q3 2022, with a 5-year trough of 0.02% in Q3 2025.
  • Moreover, its 5-year median value for Return on Assets was 0.04% (2021), whereas its average is 0.05%.
  • Within the past 5 years, the most significant YoY rise in AbbVie's Return on Assets was 500bps (2021), while the steepest drop was -600bps (2021).
  • Quarter analysis of 5 years shows AbbVie's Return on Assets stood at 0.08% in 2021, then increased by 8bps to 0.08% in 2022, then crashed by -57bps to 0.04% in 2023, then dropped by -14bps to 0.03% in 2024, then plummeted by -43bps to 0.02% in 2025.
  • Its last three reported values are 0.02% in Q3 2025, 0.03% for Q2 2025, and 0.03% during Q1 2025.